Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación
Artículo científico (JournalArticle)
Sleep efficiency predicts next-day glycaemia and daytime glycaemia influences sleep in free-living adults at risk of type 2 diabetes
Aim: To investigate how sleep features influence next-day diurnal glucose homeostasis and vice versa in free-living adults at
risk of type 2 diabetes. Materials and Methods: This observational repeated-measures study included 388 adults aged 25–65years (50% women) with
overweight or obesity (BMI ≥25.0–<40.0kg/m2
). Sleep and glucose homeostasis were simultaneously assessed over 14days
using wrist-worn accelerometers and continuous glucose monitors. Linear mixed models evaluated day-level associations between sleep metrics—wake-up time, sleep period time (i.e., time from sleep onset to wake-up) and sleep efficiency ([total sleep
time/sleep period time]×100)—and diurnal glucose metrics, including mean glucose and its standard deviation (glycaemic
variability). Results: We analysed 3942 valid person-days. Each 1% increase in sleep efficiency was associated with lower next-day mean glucose (B [95% CI]=−0.05 [−0.08, −0.01] mg/dL; p=0.007). Each 1h delay in wake-up time was linked to reduced next-day glucose
variability (−0.24 [−0.38, −0.10] mg/dL; p=0.001). Conversely, each 1mg/dL increase in daytime mean glucose was associated
with later wake-up time (0.008 [0.002, 0.014]h; p=0.008), longer sleep period time (0.006 [0.000, 0.012] h; p=0.039) and lower
sleep efficiency (−0.05% [−0.08%, −0.01%] %; p=0.005) the subsequent night. Each 1mg/dL increase in glucose variability was
associated with earlier wake-up time (−0.02 [−0.03, −0.01]h; p<0.001). Conclusions: This study provides evidence that sleep and glucose dynamics are temporally associated in free-living adults at
risk of type 2 diabetes. These findings underscore the potential of combining sleep and glucose metrics to inform cardiometabolic
risk prevention strategies., This study (Project ref. PID2022.141506OB.I00) is funded by the MCIU/AEI/10.13039/501100011033 and by ERDF, EU a way of making Europe to J.R.R.; Junta de Andalucía, Consejería de Transformación económica, Industria, Conocimiento y Universidades (A-CTS-516-UGR20) to J.R.R.; the University of Granada Plan Propio de Investigación-Excellence actions: Unit of Excellence on Exercise Nutrition and Health (UCEENS) to J.R.R.; the Consejo Superior de Deportes, Ministerio de Cultura y Deporte, Plan de Recuperación, Transformación y Resiliencia, Funded by the European Union -NextGenerationEU (EXP_75091) to I.L.; the Government of Navarra, Departamento de Desarrollo Economico y Empresarial (0011-1365-2021-00070), Plan de Promoción de Grupos de Investigación de la Universidad Pública de Navarra to I.L.; Spanish Ministry of Universities (FPU21/01161 to A.C.-J., FPU22/01631 to J.J.M.-O., FPU23/02158 to M.M.-F., and FPU18/03357 to M.D.M). J.H.M. is supported by grant RYC2024-050453-I funded by MCIN/AEI/10.13039/501100011033. A.C.-C. is supported by the Junta de Andalucía, Consejería de Salud y Consumo (RHJ-0098-2024). J.M. is supported by the Novo Nordisk Foundation grant NNF23SA0084103, the EFSD/Novo Nordisk Foundation Future Leaders Award (no. 0094134) and the European Union (HORIZONEIC-2023-PATHFINDERCHALLENGES-01-101161509). In addition, funding was provided from the EXERNET Research Network on Exercise and Health (DEP2005-00046/ACTI; 09/UPB/19; 45/UPB/20; 27/UPB/21 to I.L. and J.R.R.). Instituto de Salud Carlos III, MCIU/AES and by ERDF, EU a way of making Europe (PI24/01360).
Proyecto:
European Commission / Horizon Europe 101161509
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-141506OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2024-2027 RYC2024-050453-I
,
ISCIII / Plan Estatal de Investigación Científica PI24-01360
,
Gobierno de Navarra / Técnica y de Innovación 2021-2023 0011-1365-2021-00070